See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Case Resolution

Presenter: Antonio Colombo

October 29, 2013

Presentation TCT 2013

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Presenter: Rudiger Lange

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Presentation TCT 2013

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Presenter: Iakshmana Pendyala

October 29, 2013

Presentation TCT 2013

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Presentation TCT 2013

Featured Trial of the Day: SAFE-PCI: A Prospective, Registry-Based, Randomized Trial of Radial vs. Femoral Vascular Access in Women Undergoing Diagnostic Cardiac Catheterization...

Presenter: Sunil Rao

October 29, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Advertisement

Slides

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Case Resolution

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Featured Trial of the Day: SAFE-PCI: A Prospective, Registry-Based, Randomized Trial of Radial vs. Femoral Vascular Access in Women Undergoing Diagnostic Cardiac Catheterization...

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content